Literature DB >> 15220439

Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.

Peter C Chien1, Sandra Cohen, Michael Tuen, James Arthos, Pei-de Chen, Sukeshi Patel, Catarina E Hioe.   

Abstract

T-helper responses are important for controlling chronic viral infections, yet T-helper responses specific to human immunodeficiency virus type 1 (HIV-1), particularly to envelope glycoproteins, are lacking in the vast majority of HIV-infected individuals. It was previously shown that the presence of antibodies to the CD4-binding domain (CD4bd) of HIV-1 glycoprotein 120 (gp120) prevents T-helper responses to gp120, but their suppressive mechanisms were undefined (C. E. Hioe et al., J. Virol. 75:10950-10957, 2001). The present study demonstrates that gp120, when complexed to anti-CD4bd antibodies, becomes more resistant to proteolysis by lysosomal enzymes from antigen-presenting cells such that peptide epitopes are not released and presented efficiently by major histocompatibility complex class II molecules to gp120-specific CD4 T cells. Antibodies to other gp120 regions do not confer this effect. Thus, HIV may evade anti-viral T-helper responses by inducing and exploiting antibodies that conceal the virus envelope antigens from T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220439      PMCID: PMC434093          DOI: 10.1128/JVI.78.14.7645-7652.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes.

Authors:  C J Schröter; M Braun; J Englert; H Beck; H Schmid; H Kalbacher
Journal:  J Immunol Methods       Date:  1999-07-30       Impact factor: 2.303

2.  HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.

Authors:  V Piguet; L Wan; C Borel; A Mangasarian; N Demaurex; G Thomas; D Trono
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

Review 3.  Proteolysis in MHC class II antigen presentation: who's in charge?

Authors:  J A Villadangos; H L Ploegh
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

Review 4.  The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation.

Authors:  T Y Nakagawa; A Y Rudensky
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

5.  Energetics of the HIV gp120-CD4 binding reaction.

Authors:  D G Myszka; R W Sweet; P Hensley; M Brigham-Burke; P D Kwong; W A Hendrickson; R Wyatt; J Sodroski; M L Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells.

Authors:  C Cicala; J Arthos; A Rubbert; S Selig; K Wildt; O J Cohen; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

7.  Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones.

Authors:  D Fenoglio; G Li Pira; L Lozzi; L Bracci; D Saverino; P Terranova; L Bottone; S Lantero; A Megiovanni; A Merlo; F Manca
Journal:  J Acquir Immune Defic Syndr       Date:  2000-01-01       Impact factor: 3.731

8.  Anti-CD4-binding domain antibodies complexed with HIV type 1 glycoprotein 120 inhibit CD4+ T cell-proliferative responses to glycoprotein 120.

Authors:  C E Hioe; G J Jones; A D Rees; S Ratto-Kim; D Birx; C Münz; M K Gorny; M Tuen; S Zolla-Pazner
Journal:  AIDS Res Hum Retroviruses       Date:  2000-06-10       Impact factor: 2.205

9.  Inhibition of antigen-induced T-cell clone proliferation by antigen-specific antibodies.

Authors:  G Corradin; H D Engers
Journal:  Nature       Date:  1984 Apr 5-11       Impact factor: 49.962

10.  HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.

Authors:  Peter C Chien; Daniel Chen; Pei-De Chen; Michael Tuen; Sandra Cohen; Stephen A Migueles; Mark Connors; Eric Rosenberg; Uma Malhotra; Charles Gonzalez; Catarina E Hioe
Journal:  J Infect Dis       Date:  2004-02-06       Impact factor: 5.226

View more
  15 in total

1.  In vivo alteration of humoral responses to HIV-1 envelope glycoprotein gp120 by antibodies to the CD4-binding site of gp120.

Authors:  Maria Luisa Visciano; Michael Tuen; Miroslaw K Gorny; Catarina E Hioe
Journal:  Virology       Date:  2007-12-04       Impact factor: 3.616

2.  Structural Basis for CD4+ T Cell Epitope Dominance in Arbo-Flavivirus Envelope Proteins: A Meta-Analysis.

Authors:  Samuel J Landry; Daniel L Moss; Da Cui; Ryan P Ferrie; Mitchell L Fullerton; Evan A Wells; Lu Yang; Nini Zhou; Thomas Dougherty; Ramgopal R Mettu
Journal:  Viral Immunol       Date:  2017-06-14       Impact factor: 2.257

3.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.

Authors:  Jason G Williams; Kenneth B Tomer; Catarina E Hioe; Susan Zolla-Pazner; Philip J Norris
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

5.  Improving immunogenicity of HIV-1 envelope gp120 by glycan removal and immune complex formation.

Authors:  Rajnish Kumar; Michael Tuen; Hualin Li; Doris B Tse; Catarina E Hioe
Journal:  Vaccine       Date:  2011-09-23       Impact factor: 3.641

6.  Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.

Authors:  Christine Hager-Braun; Elisabeth O Hochleitner; Miroslaw K Gorny; Susan Zolla-Pazner; Rachelle J Bienstock; Kenneth B Tomer
Journal:  J Am Soc Mass Spectrom       Date:  2010-03-31       Impact factor: 3.109

7.  Targeting a Neutralizing Epitope of HIV Envelope Gp120 by Immune Complex Vaccine.

Authors:  Rajnish Kumar; Maria Luisa Visciano; Hualin Li; Catarina Hioe
Journal:  J AIDS Clin Res       Date:  2012-03-09

8.  Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.

Authors:  Johannes S Gach; Kane J V Mara; Celia C LaBranche; Marit J van Gils; Laura E McCoy; P J Klasse; David C Montefiori; Rogier W Sanders; John P Moore; Donald N Forthal
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120.

Authors:  Catarina E Hioe; Maria Luisa Visciano; Rajnish Kumar; Jianping Liu; Ethan A Mack; Rachel E Simon; David N Levy; Michael Tuen
Journal:  Vaccine       Date:  2009-10-29       Impact factor: 3.641

10.  Reconstruction of a pathway of antigen processing and class II MHC peptide capture.

Authors:  Catherine X Moss; Timothy I Tree; Colin Watts
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.